» Articles » PMID: 34903110

Turkish and Moroccan Dutch Women's Views of Using a Self-sampling Kit for Human Papillomavirus Testing As a Tool for Cervical Cancer Screening: What Are the Barriers and the Motivators?

Overview
Date 2021 Dec 14
PMID 34903110
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study explores barriers and motivators to use self-sampling kits for human papillomavirus testing for cervical cancer screening as perceived by Dutch women of Turkish and Moroccan origin living in the Netherlands.

Methods: A total of 11 in-depth semi-structured interviews were conducted and structured according to the theory of planned behavior.

Results: Findings suggest that self-sampling may lift important barriers hampering traditional cervical cancer screening, such as those related to shame and chastity. However, self-sampling raises its own barriers too. Most importantly, some women fear that self-sampling may harm virginity. Some women also do not feel confident about their ability to properly use the self-sampling kit, but fears about the inability to properly use it often fade away upon having seen the self-sampling kit. Moreover, results show that knowledge about cervical cancer and its origin is limited, which may undermine women's willingness to participate in a screening program.

Conclusions: These results suggest that communication strategies to encourage using self-sampling kits among women of Turkish and Moroccan origin could benefit from culturally sensitive approaches, for example, by placing emphasis on issues such as virginity and chastity. Consistent with a recent advice of the Health Council of the Netherlands, the kit could furthermore be sent to eligible women as a standard procedure, rather than upon request. This could reduce hassle and doubts about women's ability to use the self-sampling kit. Finally, educating women about the importance of screening to prevent cervical cancer is needed to foster informed decision-making.

Citing Articles

Experiences and perspectives regarding human papillomavirus self-sampling in sub-Saharan Africa: A systematic review of qualitative evidence.

Dzobo M, Dzinamarira T, Jaya Z, Kgarosi K, Mashamba-Thompson T Heliyon. 2024; 10(12):e32926.

PMID: 39021965 PMC: 11253232. DOI: 10.1016/j.heliyon.2024.e32926.

References
1.
Zhao X, Nan X . The Influence of Absolute and Comparative Risk Perceptions on Cervical Cancer Screening and the Mediating Role of Cancer Worry. J Health Commun. 2015; 21(1):100-8. DOI: 10.1080/10810730.2015.1033114. View

2.
Verdoodt F, Jentschke M, Hillemanns P, Racey C, Snijders P, Arbyn M . Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015; 51(16):2375-85. DOI: 10.1016/j.ejca.2015.07.006. View

3.
Bosgraaf R, Ketelaars P, Verhoef V, Massuger L, Meijer C, Melchers W . Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med. 2014; 64:108-13. DOI: 10.1016/j.ypmed.2014.04.011. View

4.
Daponte A, Pournaras S, Tsakris A . Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?. Womens Health (Lond). 2014; 10(2):115-8. DOI: 10.2217/whe.14.8. View

5.
Ketelaars P, Bosgraaf R, Siebers A, Massuger L, van der Linden J, Wauters C . High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study. Prev Med. 2017; 101:96-101. DOI: 10.1016/j.ypmed.2017.05.021. View